Slovakia – Pharmaceutical products – LIEKY PRE BIOLOGICKÚ LIEČBU 2026
Národný ústav reumatických chorôb
Buyer country
Slovakia
Publication date
Not specified
Biderra sector
Pharma and laboratory
Data source
TED open data
Decision signals
First-pass opportunity review
These signals are calculated from the indexed fields. They help prioritize a review but do not replace eligibility checks in the official procurement documents.
- Timing signal
- Deadline not indexed
- Indexed data completeness
- 71%
- Official title coverage
- 7 languages
- Classification signal
- 33600000
Check the official notice
Based on seven decision fields
Preserved from source-supplied versions
Medical equipment, pharmaceuticals and personal care products
Official title versions
TED may publish the same notice title in several official languages. Biderra preserves the versions supplied in the source feed.
Eslovaquia – Productos farmacéuticos – LIEKY PRE BIOLOGICKÚ LIEČBU 2026
Slowakije – Farmaceutische producten – LIEKY PRE BIOLOGICKÚ LIEČBU 2026
Słowacja – Produkty farmaceutyczne – LIEKY PRE BIOLOGICKÚ LIEČBU 2026
Slovaquie – Produits pharmaceutiques – LIEKY PRE BIOLOGICKÚ LIEČBU 2026
Slowakei – Arzneimittel – LIEKY PRE BIOLOGICKÚ LIEČBU 2026
Slovacchia – Prodotti farmaceutici – LIEKY PRE BIOLOGICKÚ LIEČBU 2026
Slovakia – Pharmaceutical products – LIEKY PRE BIOLOGICKÚ LIEČBU 2026
What Biderra adds
For notice 591963-2026, Biderra has normalized the contracting authority country as Slovakia, grouped CPV 33600000 under pharma and laboratory, compared the available deadline fields with today, measured field completeness, and preserved 7 source-supplied title versions. The official record remains decisive.